Gujarat Terce Laboratories Ltd - 524314 - Board Meeting Outcome for Outcome Of Board Meeting Held On 29 May 2026
Gujarat Terce Labs announced Q4 FY26 revenue of ₹11.40 crores (down 8.15% YoY) and net profit of ₹0.10 crores (from loss of ₹3.39 crores YoY). The board also approved the re-appointment of Mr. Aalap Prajapati as Managing Director & CEO for a five-year term starting October 28, 2026, pending shareholder approval.
May 29 2026 22:39:14
Gujarat Terce Laboratories Ltd - 524314 - Announcement under Regulation 30 (LODR)-Change in Directorate
Gujarat Terce Laboratories' Board has approved the re-appointment of Mr. Aalap Prajapati as the Managing Director & CEO for a 5-year term, effective October 28, 2026, subject to shareholder approval. This ensures leadership continuity for the micro-cap company.
May 29 2026 22:31:45
Gujarat Terce Laboratories Ltd - 524314 - Update on board meeting
Gujarat Terce Laboratories has rescheduled its board meeting to May 29, 2026. The meeting will consider and approve the audited standalone financial results for the fourth quarter and fiscal year ended March 31, 2026.
May 26 2026 17:27:10
Gujarat Terce Laboratories Ltd - 524314 - Board Meeting Intimation for Consideration Of Annual Audited Standalone Financial Results Of The Company For The Fourth Quarter And FY Ended 31 March 2026 And Any Other Matter.
Gujarat Terce Laboratories' board meeting is scheduled for May 27, 2026. The agenda includes the consideration and approval of the annual audited standalone financial results for the fourth quarter and full financial year ending March 31, 2026, and matters related to the upcoming Annual General Meeting.
May 13 2026 16:27:24
Read More